Published in N Engl J Med on March 28, 1974
Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol (2010) 1.16
Factors in the differential rate of arteriosclerosis (AS) between long surviving renal transplant recipients and dialysis patients. Ann Surg (1976) 0.96
High-output congestive failure from femoral arteriovenous shunts for vascular access. Ann Surg (1976) 0.88
Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. J Clin Invest (1986) 0.88
The use of erythropoietin in renal failure. Postgrad Med J (1991) 0.80
Factors associated with hospitalization in a sample of chronic hemodialysis patients. Health Serv Res (1991) 0.77
The quality of life of patients with end-stage renal disease. N Engl J Med (1985) 5.10
The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med (1993) 4.88
Preoperative renal risk stratification. Circulation (1997) 3.47
Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34
Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med (1995) 3.13
Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int (2006) 2.76
Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med (1968) 2.70
Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med (1970) 2.43
Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int (1999) 2.40
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med (1981) 2.21
Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int (2000) 2.19
Initiation of dialysis. J Am Soc Nephrol (1995) 2.16
Intrarenal distribution of blood flow in the transplanted dog kidney: effect of denervation and rejection. J Clin Invest (1967) 2.14
Dose of hemodialysis and survival: differences by race and sex. JAMA (1998) 2.08
Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med (1967) 2.06
Limitations of the facility-specific standardized mortality ratio for profiling health care quality in dialysis. Am J Kidney Dis (2001) 2.03
Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01
The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med (1973) 1.92
The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace. N Engl J Med (1981) 1.88
Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis (2001) 1.85
Subtotal parathyroidectomy in chronic renal failure: a seven-year experience in a dialysis and transplant program. Ann Surg (1971) 1.83
Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury. N Engl J Med (1968) 1.80
Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med (1973) 1.74
C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int (1998) 1.73
Cardiac arrest and sudden death in dialysis units. Kidney Int (2001) 1.67
Human renal isografts: a clinical and pathologic analysis. Medicine (Baltimore) (1968) 1.63
Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62
Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy. Medicine (Baltimore) (1969) 1.61
Quality-of-life evaluation using Short Form 36: comparison in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis (2000) 1.60
Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57
Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int (1999) 1.56
Glomerulonephritis (third of three parts). N Engl J Med (1974) 1.52
Restless legs syndrome in end-stage renal disease. Am J Kidney Dis (1996) 1.50
Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis (1997) 1.48
Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med (1996) 1.48
Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med (1978) 1.45
Senescence and the renal vasculature in normal man. Circ Res (1974) 1.43
Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation. Am J Med (1967) 1.42
Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg (1985) 1.40
Modeling mortality risk in hemodialysis patients using laboratory values as time-dependent covariates. Am J Kidney Dis (1996) 1.40
Intravascular coagulation (IVC) in human renal allograft rejection. Transplant Proc (1969) 1.39
Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. Kidney Int (2000) 1.38
Bacteremic infection in hemodialysis. Arch Intern Med (1979) 1.34
Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J Am Soc Nephrol (1998) 1.33
Simplified hippuran clearance. Measurement of renal function in man with simplified hippuran clearances. Nephron (1966) 1.33
Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest (1966) 1.30
Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) (1968) 1.28
Bioimpedance norms for the hemodialysis population. Kidney Int (1997) 1.27
Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol (1995) 1.25
Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med (1984) 1.25
The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int (1999) 1.24
Renal transplantation in the inbred rat. I. Morphologic, immunologic, and functional alterations during acute rejection. Transplantation (1967) 1.22
Sauna baths in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs (1966) 1.22
Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis (1999) 1.22
Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int (1994) 1.21
Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol (1997) 1.21
Uremic pericarditis. Clinical features and management. Circulation (1968) 1.20
Human renal allografts. Interpretation of morphologic and immunohistochemical observations. Am J Pathol (1968) 1.19
An immunosupressive site of action of heterologous antilymphocyte serum. Lancet (1967) 1.17
Liver disease in kidney transplant patients receiving azathioprine. Arch Intern Med (1973) 1.15
Renal transplantation in the inbred rat. II. An immunohistochemical study of acute allograft rejection. Am J Pathol (1968) 1.14
Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.13
Effect of sodium balance on intrarenal distribution of blood flow in normal man. J Appl Physiol (1970) 1.13
Cellular immunity in the mouse. II. Correlation of in vivo and in vitro phenomena. Cell Immunol (1972) 1.12
Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences. Arch Intern Med (1973) 1.11
Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy. Arch Intern Med (1978) 1.10
Cellular immunity in the mouse. I. In vitro lymphocyte reactivity. Cell Immunol (1972) 1.10
Arterial oxygenation during hemodialysis. N Engl J Med (1977) 1.10
Diffusion of glucose, insulin, inulin, and Evans blue protein into thoracic duct lymph of man. J Clin Invest (1967) 1.10
Effect of total parathyroidectomy and uremia on the chemical composition of bone, skin and aorta in the rat. Isr J Med Sci (1971) 1.09
Glomerulonephritis in renal transplants. Transplant Proc (1969) 1.09
Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE). J Clin Invest (1969) 1.08
Cholinergic augmentation of lymphocyte-mediated cytotoxicity. A study of the cholinergic receptor of cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1974) 1.07
Factitious feculent urine in an adolescent boy. JAMA (1977) 1.06